Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 26Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Prostatic Neoplasms 8Multiple Myeloma 7Lung Neoplasms 7Melanoma 6Stomach Neoplasms 5Leukemia, Myeloid, Acute 5Glioma 4Colorectal Neoplasms 4Carcinoma, Hepatocellular 4Tuberous Sclerosis 3Sarcoma 3Papillomavirus Infections 3Neoplasm Metastasis 3Hematologic Neoplasms 3Glioblastoma 3Warts 2Venous Thromboembolism 2Thyroid Neoplasms 2Skin Neoplasms 2Rectal Neoplasms 2Polycythemia Vera 2Pain 2Ovarian Neoplasms 2Oligodendroglioma 2Obesity 2Neoplasms by Site 2Myasthenia Gravis 2

Interventions

human papillomavirus vaccine, L1 type 16, 18 1adacel 1Tetanus Toxoid 1Human Papillomavirus Recombinant Vaccine nonavalent 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Human Papillomavirus-Related Cervical Carcinoma × 90 days × Clear all
NCT05237947 2026-05-28

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting
5,000 enrolled
Gynecologic

Human Papillomavirus-Related Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡